## 



## 

||**Page**|
|---|---|
|Legal andadministrativeinformation.............................................|1 - 2|
|Structure,Governance, andManagement...................................... .|3 - 6|
|ReportoftheBoardofTrustees .........................................................|7 - 15|
|Independentauditors'report............................................................|16- 19|
|Consolidatedstatementoffinancialactivities..............................|20|
|Consolidated balancesheet.............................................................. .|21|
|Consolidatedstatementofcash flows ............................................ .|22|
|Notestothefinancialstatements .................................................. .|23- 39|





## 

## 



## 

## 

## 

|**Auditors**||
|---|---|
||Moore KingstonSmithLLP|
||9 AppoldStreet|
||London|
||EC2A 2AP|
|**Bankers**|HSBC Bank pie|
||Oxford Circus Branch|
||196OxfordStreet|
||London|
||WlDlNT|
||Lloyds Bank|
||21-31 WhiteHartStreet|
||HighWycombe|
||Buckinghamshire|
||HPll2HL|
|**Investmentmanager**|Cazenove Capital|
||1 London Wall Place,|
||London|
||EC2YSAU|
|**Solicitors**|Blaser Mills|
||Park House|
||40Oxford Road|
||High Wycombe|
||Buckinghamshire|
||HPll2EE|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 




## 




## 




## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 





## 

|**Notes**<br>**Income**<br>Donations and legacies<br>2<br>Income from charitable activities<br>2<br>Income from trading activities<br>2<br>Investment income<br>2<br>**Total income**<br>**Expenditure**<br>Expenditureonraising funds<br>Donations and legacies<br>Trading activities<br>Expenditureoncharitable activities<br>3<br>Other expenditure<br>**Total expenditure**<br>**Net**losseson investments<br>11<br>**Net income for the year**<br>7<br>**Balancesbrought forward**<br>**Total funds carried forward **|<br>**Unrestricted**<br>**funds**<br>(£)<br>1,339,416<br>2,005,153<br>437,395<br>13,918<br>3,795,882<br>241,092<br>326,531<br>2,813,152<br>24,158<br>3,404,933<br>(15,949)<br>375,000<br>1,661,718|**Restricted**<br>**2022**<br>**Unrestricted**<br>**Restricted**<br>**2021**<br>**funds**<br>**Total**<br>**funds**<br>**funds**<br>**Total**<br>(£)<br>(£)<br>(£)<br>(£)<br>(£)<br>226,686<br>1,566,102<br>856,223<br>52,123<br>908,346<br>27,778<br>2,032,931<br>1,700,475<br>232,490<br>1,932,965<br>1,078<br>438,473<br>739,494<br>2,429<br>741,923<br>3,015<br>16,933<br>146<br>1,542<br>1,688<br>~~258,557~~<br>~~4,054,439~~<br>~~3,296,338~~<br>~~288,584~~<br>3,584,922<br>241,092<br>300,166<br>1,966<br>302,132<br>326,531<br>593,950<br>2,429<br>596,379<br>110,679<br>2,923,831<br>2,370,781<br>121,786<br>2,492,567<br>24,158<br>110,679<br>~~3,515,612~~<br>~~3,264,897~~<br>~~126,181~~<br>~~3,391,078~~<br>(203)<br>(16,152)<br>147,675<br>522,675<br>31,441<br>162,403<br>193,844<br>419,180<br>~~2,080,898~~<br>~~1,630,277~~<br>~~256,777~~<br>~~1,887,054~~<br>566,855<br>~~2,603,573~~<br>~~1,661,718~~<br>~~419,180~~<br>~~2,080,898~~|
|---|---|---|
||2,036,718||





## 

## 

## 

|**Notes**<br>**FIXEDASSETS**<br>Intangible assets<br>10<br>Tangible assets<br>10<br>Investments<br>11<br>**CURRENTASSETS**<br>Investment & deposits<br>11<br>Debtors<br>12<br>CashatBank<br>**CURRENTLIABILITIES**<br>Creditors - falling duewithinone year<br>13<br>**NETCURRENTASSETS**<br>**Totalassetslesscurrent liabilities**<br>**Provisions forliabilities andcharges**<br>14<br>**NETASSETS**<br>**Thefunds ofthecharity**<br>Unrestricted funds<br>Designated<br>15<br>General<br>Restrictedfunds<br>16<br>**Total charity funds**|**Group**<br>**2022**<br>**2021**<br>£<br>£<br>105,264<br>28,568<br>46,347<br>323,848<br>457,680<br>46,347<br>623,357<br>954,953<br>1,008,099<br>455,781<br>1,692,267<br>1,817,837<br>3,323,723<br>3,228,571<br>(1,137,830)<br>{1,154,022)<br>2,185,893<br>2,074,549<br>2,643,573<br>2,120,896<br>(40,000)<br>(40,000)<br>2,603,573<br>2,080,896<br>98,291<br>93,566<br>1,938,427<br>1,568,152<br>2,036,718<br>1,661,718<br>566,855<br>419,180<br>**2,603,573**<br>**2,080,898**|**Group**<br>**2022**<br>**2021**<br>£<br>£<br>105,264<br>28,568<br>46,347<br>323,848<br>457,680<br>46,347<br>623,357<br>954,953<br>1,008,099<br>455,781<br>1,692,267<br>1,817,837<br>3,323,723<br>3,228,571<br>(1,137,830)<br>{1,154,022)<br>2,185,893<br>2,074,549<br>2,643,573<br>2,120,896<br>(40,000)<br>(40,000)<br>2,603,573<br>2,080,896<br>98,291<br>93,566<br>1,938,427<br>1,568,152<br>2,036,718<br>1,661,718<br>566,855<br>419,180<br>**2,603,573**<br>**2,080,898**||**Charity**<br>**2022**<br>**2021**<br>£<br>£<br>105,264<br>28,568<br>46,347<br>323,850<br>2|**Charity**<br>**2022**<br>**2021**<br>£<br>£<br>105,264<br>28,568<br>46,347<br>323,850<br>2|
|---|---|---|---|---|---|
|||46,347<br>954,953<br>455,781<br>1,817,837<br>3,228,571<br>{1,154,022)<br>2,074,549<br>2,120,896<br>(40,000)<br>2,080,896<br>93,566<br>1,568,152<br>1,661,718<br>419,180<br>**2,080,898**||457,682<br>623,357<br>1,211,568<br>1,431,807|46,349<br>954,953<br>586,292<br>1,605,392|
|||||3,266,732<br>(1,080,839)|3,146,637<br>{1,072,088)|
||2,185,893|||2,185,893|~~2,074,549~~|
||2,643,573<br>(40,000)|||2,643,574<br>(40,000)<br>2,603,574<br>98,291<br>1,938,429|<br>2,120,898<br>(40,000)|
||2,603,573||||2,080,898|
||98,291<br>1,938,427||||93,566<br>1,568,152|
||2,036,718<br>566,855|||2,036,720<br>566,855|1,661,718<br>419,180|
||**2,603,573**|||**2,603,575**|**2,080,898**|





## 

## 

## 

|**Cashflowsfromoperating activities:**<br>Netcashprovidedbyoperatingactivities<br>**Cashflows from investing activities:**<br>Dividends, interestandrentsfrominvestments<br>Bankinterest<br>Purchaseofintangible andtangiblefixedassets<br>Purchaseofinvestments<br>Saleofinvestments<br>Netcash used in investing activities<br>**Increase**in**cashand cash equivalents**in**theyear**<br>**Cash and cash equivalentsatthebeginningoftheyear**<br>**Totalcashandcash equivalentsatthe endoftheyear**<br>Notes<br>22<br>23<br>23|**2022**<br>£<br>(119)<br>2,099<br>14,833<br>(133,980)<br>(340,000)<br>(457,048)<br>(457,167)<br>2,772,790<br>2,315,623|**2021**<br>£<br>75,929<br>1,688<br>(9,582)<br>(7,894)<br>68,035<br>2,704,755|
|---|---|---|
|||2,772,790|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

|**2**<br>**INCOME**<br>**Unrestricted**<br>**Incomefrom donations andlegacies**<br>Donations and gifts<br>631,181<br>Legacies<br>708,235<br>**1,339,416 **<br>**Incomefrom charitableactivities**<br>Membership<br>1,180,435<br>Raising Awareness<br>792,249<br>Research<br>Groups<br>32,469<br>**2,005,153**<br>**Incomefromtradingactivities**<br>Raffle and lottery<br>426,038<br>Othercommercial activities<br>11,357<br>**437,395**<br>**Investment**Income<br>Investments - dividends<br>2,099<br>Bank interest<br>11,819<br>**13,918 **|**2**<br>**INCOME**<br>**Unrestricted**<br>**Incomefrom donations andlegacies**<br>Donations and gifts<br>631,181<br>Legacies<br>708,235<br>**1,339,416 **<br>**Incomefrom charitableactivities**<br>Membership<br>1,180,435<br>Raising Awareness<br>792,249<br>Research<br>Groups<br>32,469<br>**2,005,153**<br>**Incomefromtradingactivities**<br>Raffle and lottery<br>426,038<br>Othercommercial activities<br>11,357<br>**437,395**<br>**Investment**Income<br>Investments - dividends<br>2,099<br>Bank interest<br>11,819<br>**13,918 **|**Restricted**<br>£<br>186,659<br>40,027<br>**226,686**|**2022 **<br>**Total**<br>£<br>817,840<br>748,262<br>**1,566,102 **<br>1,180,435<br>820,027<br>32,469<br>**2,032,931**<br>426,038<br>12,435<br>**438,473**|**Unrestricted**<br>656,019<br>200,203|**Restricted**<br>£<br>52,123|**2021**<br>**Total**<br>£<br>708,142<br>200,203|
|---|---|---|---|---|---|---|
||**1,339,416 **<br>1,180,435<br>792,249<br>32,469|||**856,222**<br>1,226,732<br>469,140<br>4,603<br>**1,700,475**|**52,123**|**908,346**|
|||27,778|||1,454<br>229,992<br>802<br>242<br>**232,490**|1,228,186<br>699,132<br>802<br>4,845|
||**2,005,153**<br>426,038<br>11,357|**27,778**||||**1,932,965**|
|||1,078||436,308<br>303,187<br>**739,495**<br>146<br>**146 **|1,024<br>1,405<br>**2,429**<br>1,542<br>**1,542 **|437,332<br>304,592|
||**437,395**<br>2,099<br>11,819<br>**13,918 **|**1,078**||||**741,923**|
|||3,015<br>**3,015**|2,099<br>14,834<br>**16,933**|||1,688<br>**1,688**|





## 

## 

|**3**<br>**Expenditure**<br>**Charitable activities**<br>Membership<br>Raising Awareness<br>Research<br>Groups|**Unrestricted**<br>£<br>1,147,572<br>1,380,566<br>135,272<br>149,742|**Restricted**<br>£<br>110,679|**2022**<br>**Total**<br>£<br>1,147,572<br>1,491,245<br>135,272<br>149,742|
|---|---|---|---|
||**2,813,152**|**110,679**|**2,923,831**|



## 

|**Breakdownofcostsofcharitable activities**|||||
|---|---|---|---|---|
|Membership<br>Raising Awareness<br>Research<br>Groups<br>**Research cost breakdown**<br>DirectResearch costs<br>Supportcosts|**Directcosts**<br>841,279<br>1,075,455<br>90,754<br>98,281<br>**2,105,769**|**Grantsmade**<br>**(notes 6)**|**Supportcosts**<br>**(note 4,5)**<br>306,293<br>415,790<br>44,518<br>51,461|**2022**<br>**Total**<br>1,147,572<br>1,491,245<br>135,272<br>149,742|
||||**818,062**<br>**Grants made**<br>38,387|**2,923,831**<br>**2022**<br>95,596<br>44,518|
|||**Directcosts**<br>95,596<br>6,131|||
|||**101,727**|**38,387**|**140,114**|





## 

## 

## 

|**3**<br>**Expenditure**<br>**Charitable activities**<br>Membership<br>Raising Awareness<br>Resea rch<br>Groups<br>**Breakdownofcostsofcharitable activities**<br>Membership<br>Raising Awareness<br>Research<br>Groups<br>**Research cost breakdown**<br>Direct Research costs<br>Supportcosts|**Directcosts**<br>836,857<br>727,977<br>64,686<br>72,131<br>**1,701,651**|**Unrestricted**<br>£<br>1,120,163<br>984,816<br>145,513<br>120,289<br>**2,370,781**|**Restricted**<br>£<br>1,454<br>116,404<br>3,686<br>242|**2021**<br>**Total**<br>£<br>1,121,617<br>1,101,220<br>149,198<br>120,531<br>**2,492,566**<br>**2021**<br>**Total**<br>1,121,617<br>1,101,221<br>149,198<br>120,531|
|---|---|---|---|---|
||||**121,786**||
|||**Grants made**<br>**(notes 6)**<br>46,250<br>**46,250**|**Supportcosts**<br>**(note 4,S)**<br>284,760<br>373,243<br>38,262<br>48,401||
||||**744,666**|**2,492,567**<br>**2021**<br>110,936<br>38,262|
|||**Direct costs**<br>64,686<br>6,683<br>**71,369**|**Grants made**<br>46,250<br>31,579||
||||**77,829**|**149,198**|





## 

## 

## 

|**4**<br>**Total supportcostbreakdownbyactivity**<br>Costofraising funds (notes5)<br>Donations and legacies<br>Trading activities<br>Charitable activities(note3)<br>Costofraising funds (notesS)<br>Donations and legacies<br>Trading activities<br>Charitable activities(note 3)|**Staffcosts**<br>£<br>25,154<br>22,542<br>330,713<br>**378,409**|**Othercosts**<br>£<br>37,510<br>33,615<br>493,156<br>**564,281**|**2022**<br>**Total**<br>£<br>62,664<br>56,157<br>823,869<br>**942,690**|
|---|---|---|---|
||**Staffcosts**<br>£<br>30,399<br>17,079<br>270,646|Othercosts<br>£<br>50,782<br>29,913<br>474,020<br>554,715|2021<br>Total<br>£<br>81,181<br>46,992<br>744,666|
||318,124||872,839|





## 

## 

|**sSupport cost apportionment**<br>**Support staff**<br>**Expenditure**on**raising**funds<br>Donations and legacies<br>25,154<br>Trading activities<br>22,542<br>**Charitable activities**<br>Membership<br>123,823<br>Raising awareness<br>168,089<br>Research<br>17,997<br>Groups<br>20,804<br>**378,409**<br>**Support staff**<br>**Expenditure**on**raising funds**<br>Donations and legacies<br>30,399<br>Trading activities<br>17,079<br>**Charitable activities**<br>Membership<br>103,495<br>Raising awareness<br>135,654<br>Research<br>13,906<br>Groups<br>17,591<br>**318,124**|**Depreciation**<br>2,832<br>2,538<br>13,942<br>18,926<br>2,026<br>2,342<br>**42,606**|**Governance**<br>1,844<br>1,652<br>9,076<br>12,320<br>1,319<br>1,525<br>**27,736**|<br>HR**costs**<br>4,847<br>4,344<br>23,861<br>32,391<br>3,468<br>4,009<br>**72,920 **|IT**costs**<br>£<br>8,951<br>8,021<br>44,060<br>59,811<br>6,404<br>7,403|**2022**<br>**Officecosts**<br>**Total**<br>£<br>£<br>19,036<br>62,664<br>17,060<br>56,157<br>93,706<br>308,468<br>127,203<br>418,740<br>13,620<br>44,834<br>15,744<br>51,827<br>**286,369**<br>**942,690**<br>**2021**<br>**Officecosts**<br>Total<br>£<br>£<br>23,825<br>81,181<br>14,034<br>46,991<br>85,044<br>284,759<br>111,471<br>373,247<br>11,426<br>38,260<br>14,455<br>48,401<br>**260,255**<br>**872,839**|
|---|---|---|---|---|---|
|||||**134,650**||
||**Depreciation**<br>6,420<br>3,782<br>22,917<br>30,039<br>3,079<br>3,895<br>**70,132**|**Governance**<br>2,009<br>1,183<br>7,170<br>9,399<br>963<br>1,219<br>**21,943**|<br>**HRcosts**<br>3,815<br>2,247<br>13,617<br>17,849<br>1,830<br>2,315<br>**41,673**|IT**costs**<br>£<br>14,713<br>8,666<br>52,516<br>68,835<br>7,056<br>8,926||
|||||**160,712**||






## 

## 

## 

|INNOVATE<br>Developmentofan Al solutionfordiagnosis and assessment<br>ofseverityofpathologyinsmallintestinal biopsies in suspected<br>or known coeliac disease(Dr Elizabeth Soilleux, Lyzeum Ltd)<br>Dissertations Awarded|**Grants to institutions**<br>**2022**<br>**2021**<br>£<br>£<br>43,750<br>2,500<br>**46,250**|**Grants to institutions**<br>**2022**<br>**2021**<br>£<br>£<br>43,750<br>2,500<br>**46,250**|
|---|---|---|
|||**46,250**|



## 

||**2022**|**2021**|
|---|---|---|
||£|£|
|Amortisation and depreciation|46,495|78,037|
|Operating lease rentals|73,049|62,598|
|Trustees liabilityinsurance|1,100|1,100|
|Audit services|13,575|10,500|
|Non - audit services provided by theauthor|||
|General advice|1,975|150|
|Tax compliance|845|350|



## 

|**2022**<br>£<br>Salaries and wages<br>1,527,899<br>Social security costs<br>162,417<br>Pension costs<br>81,842<br>**1,772,158**|**2021**<br>£<br>1,452,257<br>146,403<br>79,257|
|---|---|
||**1,677,917**|





## 

## 

## 

|**2022**||**2021**||
|---|---|---|---|
|**Number**||**Number**||
||1||1|



|Advice and information<br>Administration and support|**2022**<br>**Number**<br>39<br>7<br>**46**<br>**2021**<br>**Number**<br>35<br>8<br>**43**|
|---|---|



## 

## 

|**Cost**<br>At1 January 2022<br>Additions<br>At31December 2022<br>**Amortisation and depreciation**<br>At 1 January 2022<br>Chargeforthe year<br>At31December2022<br>**Netbook values**<br>At31December 2022<br>At31December 2021<br>**Intangible fixedassets**<br>**Total**<br>£<br>172,082<br>125,090<br>**297,172**<br>153,418<br>38,490<br>**191,908**<br>**105,264**<br>18,664|**Furniture**&<br>**fittings**<br>£<br>152,592<br>**152,592**<br>151,639<br>342<br>**Computer**<br>**equipment**<br>£<br>543,550<br>8,890<br>**552,440**<br>516,819<br>7,664<br>**Total**<br>£<br>696,142<br>8,890<br>**705,032**<br>668,458<br>8,006|
|---|---|
||**151,981**<br>**524,483**<br>**676,464**|
||**611**<br>**27,957**<br>**28,568**|
||953<br>26,731<br>27,684|





## 

## 

|MarketValueat1 January 2022<br>Additions<br>Disposals<br>Realised investment losses<br>**MarketValueat31December2022**<br>Historical costasat31 December2022|(Charity only)<br>Investments in<br>subsidiaries<br>£<br>2<br>2<br>2|Unittrusts<br>£<br>340,000<br>(16,152)<br>323,848|Total<br>2022<br>£<br>2<br>340,000<br>(16,152)<br>323,850<br>340,002|Total<br>2021<br>£<br>2|
|---|---|---|---|---|
|||||2|
|||340,000|||
|||||2|



## 

||Countryof||**Shares**held|**Shares**held|
|---|---|---|---|---|
|Company|incorporation|**Class**||%|
|The Coeliac Trading Company Ltd|England&Wales|Ordinary||100|
|The principal activityofThe Coeliac Trading Company Limited (Company number 02856981)istoraise funds|||ona commercial||
|basisforCoeliacUK(Limited by Guarantee}, a registered charity. The addressofthe registered officeisThird|||Floor, Apollo||
|Centre, Desborough Road, High Wycombe, Buckinghamshire,HPll2QW.|||||
|The aggregate amountofcapital and reserves and the resultsofthis undertakingfortheyear ended31December 2022 were:|||||
|||||Profitsto|
|||||reservesfor|
|||Capital||the**year**|
|||£||£|
|The Coeliac Trading Company Ltd|||2||



## 

|Theagrgegateofthe assets and liabilities was:<br>Income<br>Expenditure<br>GiftaidtoCoeliac UK<br>**Assets**<br>**Liabilities**|**2022**<br>£<br>290,203<br>(287,548)<br>(2,655)<br>**2022**<br>£<br>295,340<br>(295,338)<br>2|**2021**<br>£<br>288,934<br>(280,974)<br>(7,960)|
|---|---|---|
||||
|||**2021**<br>£<br>294,666<br>(294,664)|
|||2|





## 

## 

## 

|Trade debtors<br>Income tax and VAT recoverable<br>Amounts owed by group undertakings<br>Prepayments and accruedincome<br>**Creditors: amounts falling due within one year**<br>Grants payable<br>Trade creditors<br>Othertax andsocial security<br>Accruals<br>Deferred income<br>**Deferred income**- **Charity**<br>At**1**January 2022<br>Released in 2022<br>Membership, licencing, Lottery and sponsorship income<br>received in advance<br>At31December 2022||**Group**<br>**2022**<br>£<br>122,290<br>885,809<br>**1,008,099**|**Group**<br>**2022**<br>£<br>122,290<br>885,809<br>**1,008,099**|**2021**<br>£<br>152,983<br>302,798|**Charity**<br>**2022**<br>£<br>87,411<br>238,348<br>885,809<br>**1,211,568**<br>**Charity**<br>**2022**<br>£<br>194,230<br>276,495<br>2,571<br>117,062<br>490,481<br>1,080,839<br>**2022**<br>£<br>456,905<br>(401,470)<br>435,046<br>**490,481**<br>**2021**<br>£<br>70,761<br>212,733<br>302,798<br>586,292<br>**2021**<br>£<br>348,247<br>165,022<br>24,766<br>77,149<br>456,905<br>1,072,088<br>**2021**<br>£<br>562,553<br>(489,711)<br>384,123<br>**456,905**|**Charity**<br>**2022**<br>£<br>87,411<br>238,348<br>885,809<br>**1,211,568**<br>**Charity**<br>**2022**<br>£<br>194,230<br>276,495<br>2,571<br>117,062<br>490,481<br>1,080,839<br>**2022**<br>£<br>456,905<br>(401,470)<br>435,046<br>**490,481**<br>**2021**<br>£<br>70,761<br>212,733<br>302,798<br>586,292<br>**2021**<br>£<br>348,247<br>165,022<br>24,766<br>77,149<br>456,905<br>1,072,088<br>**2021**<br>£<br>562,553<br>(489,711)<br>384,123<br>**456,905**|
|---|---|---|---|---|---|---|
|||||455,781|||
|||**Group**<br>**2022**<br>£<br>194,230<br>286,136<br>11,449<br>122,112<br>523,904<br>1,137,830||**2021**<br>£<br>348,247<br>165,022<br>39,772<br>89,470<br>511,510|||
|||1,137,830||1,154,022||1,072,088<br>**2021**<br>£<br>562,553<br>(489,711)<br>384,123|
||||||**2022**<br>£<br>456,905<br>(401,470)<br>435,046||
||||||**490,481**|**456,905**|



## 

## 

|At 1 January 2022<br>Chargedfortheyear<br>At 31 December 2022|£<br>40,000<br>**40,000**|
|---|---|





## 

## 

## 

## 

|<br>designated funds were:||||
|---|---|---|---|
|**Balance at**<br>**1 January 2022**<br>Research(Innovate)<br>2,314<br>ResearchFund<br>10,194<br>Localvoluntary support groups<br>81,058<br>**93,566**<br>**Balance at**<br>**1 January 2021**<br>Research(Innovate)<br>46,064<br>ResearchFund<br>10,191<br>Local voluntary support groups<br>82,077<br>**138,332**|<br>**Incoming**<br>32,469<br>**32,469**<br> <br>**Incoming**<br>3<br>4,603<br>**4,603**|**Outgoing**<br>(27,744)|**Balance at**<br>**31December 2022**<br>2,314<br>10,194<br>85,783<br>**98,291**<br>**Balance at**<br>**31December 2021**<br>2,314<br>10,194<br>81,058|
|||**(27,744)**<br>**Outgoing**<br>(43,750)<br>(5,622)<br>**(49,369)**||
||||**93,566**|



## 

## 



## 

## 

|**16Restricted funds**- **Group and Charity**<br>**Balanceat**<br>**1January2022**<br>**Incoming**<br>Research Fund<br>277,208<br>230,577<br>Daily newspaperadvertfor<br>AwarenessWeek<br>1,477<br>41<br>Care System campaigns<br>17<br>MembershipHelpline<br>140<br>24<br>Diagnosis TV Advert<br>2,926<br>Diagnosis Life ChannelNHS<br>2,000<br>PharmacyPacks<br>1,067<br>Diagnosis campaign<br>119,767<br>27,778<br>Event sforchildrenwith<br>CDand families<br>5,000<br>DigitalCampaign<br>2,000<br>GlutenAtaxia<br>7,578<br>137<br>Sponsored Dissertations<br>**419,180**<br>**258,557**<br>**Balanceat**<br>**1January2021**<br>**Incoming**<br>Research Fund<br>230,535<br>48,015<br>Daily newspaperadvertfor<br>Awareness Week<br>1,477<br>Care System campaigns<br>17<br>MembershipHelpline<br>140<br>Diagnosis TVAdvert<br>2,926<br>Diagnosis Life ChannelNHS<br>2,000<br>PharmacyPacks<br>1,067<br>Diagnosis campaign<br>6,180<br>222,725<br>Eventsforchildrenwith<br>CDand families<br>5,000<br>GovernmentFurloughgrant<br>14,162<br>DigitalCampaign<br>2,000<br>GlutenAtaxia<br>7,578<br>256,780<br>287,042|**16Restricted funds**- **Group and Charity**<br>**Balanceat**<br>**1January2022**<br>**Incoming**<br>Research Fund<br>277,208<br>230,577<br>Daily newspaperadvertfor<br>AwarenessWeek<br>1,477<br>41<br>Care System campaigns<br>17<br>MembershipHelpline<br>140<br>24<br>Diagnosis TV Advert<br>2,926<br>Diagnosis Life ChannelNHS<br>2,000<br>PharmacyPacks<br>1,067<br>Diagnosis campaign<br>119,767<br>27,778<br>Event sforchildrenwith<br>CDand families<br>5,000<br>DigitalCampaign<br>2,000<br>GlutenAtaxia<br>7,578<br>137<br>Sponsored Dissertations<br>**419,180**<br>**258,557**<br>**Balanceat**<br>**1January2021**<br>**Incoming**<br>Research Fund<br>230,535<br>48,015<br>Daily newspaperadvertfor<br>Awareness Week<br>1,477<br>Care System campaigns<br>17<br>MembershipHelpline<br>140<br>Diagnosis TVAdvert<br>2,926<br>Diagnosis Life ChannelNHS<br>2,000<br>PharmacyPacks<br>1,067<br>Diagnosis campaign<br>6,180<br>222,725<br>Eventsforchildrenwith<br>CDand families<br>5,000<br>GovernmentFurloughgrant<br>14,162<br>DigitalCampaign<br>2,000<br>GlutenAtaxia<br>7,578<br>256,780<br>287,042|**Outgoing**<br>(110,679)<br>**(110,679)**|**Investment**<br>**gains**<br>(1,229)<br>11<br>1<br>21<br>14<br>8<br>866<br>36<br>14<br>55<br>**(203)**|**Transferof**<br>**funds**<br>(7,500)<br>7,500|**Balanceat**<br>**31December2022**<br>499,056<br>1,529<br>17<br>165<br>2,947<br>2,014<br>1,075<br>37,732<br>5,036<br>2,014<br>7,770<br>7,500<br>**566,855**<br>**Balanceat**<br>**31December2021**<br>277,208<br>1,477<br>17<br>140<br>2,926<br>2,000<br>1,067<br>119,767<br>5,000<br>2,000<br>7,578|
|---|---|---|---|---|---|
||**Balanceat**<br>**1January2021**<br>**Incoming**<br>230,535<br>48,015<br>1,477<br>17<br>140<br>2,926<br>2,000<br>1,067<br>6,180<br>222,725<br>5,000<br>14,162<br>2,000<br>7,578<br>256,780<br>287,042|**Outgoing**<br>(2,883)<br>(109,138)<br>(14,162)<br>(126,183)|**Investment**<br>**gains**<br>1,542<br>1,542|**Transferof**<br>**funds**||
||||||419,180|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|Intangible assets<br>Tangible assets<br>Investments<br>Net currentassets lessprovisionsforliabilities and charges<br>Tangible assets<br>Net currentassetslessprovisionsforliabilities and charges||**Unrestricted**<br>**funds**<br>**2022**<br>105,264<br>28,568<br>323,848<br>1,480,747<br>**1,938,427**|**Designated**<br>**funds**<br>**2022**<br>98,291<br>**98,291**|**Restricted**<br>**funds**<br>**2022**<br>566,855<br>**566,855**|**Total**<br>**2022**<br>105,264<br>28,568<br>323,848<br>2,145,893|
|---|---|---|---|---|---|
||||||**2,603,573**<br>**Total**<br>**2021**<br>46,348<br>2,034,550|
|||**Unrestricted**<br>**funds**<br>**2021**<br>46,348<br>1,521,804<br>**1,568,152**|**Designated**<br>**funds**<br>**2021**<br>93,567<br>**93,567**|**Restricted**<br>**funds**<br>**2021**<br>419,180<br>**419,180**||
||||||**2,080,898**|



## 

|**Landand**<br>**2022**<br>£<br>Withinone year<br>86,295<br>Betweentwoand five years<br>5,103<br>**91,398**|**buildings**<br>**2021**<br>£<br>86,295<br>43,486<br>**129,781**|**Office equipment**<br>**2022**<br>**2021**<br>£<br>£<br>2,991<br>3,885<br>3,132<br>6,123<br>**6,123**<br>**10,008**|**Office equipment**<br>**2022**<br>**2021**<br>£<br>£<br>2,991<br>3,885<br>3,132<br>6,123<br>**6,123**<br>**10,008**|
|---|---|---|---|
||||**10,008**|



## 

## 



## 

## 

## 

|Year|Amount|
|---|---|
|1|772|
|2|772|
|3|64|



||£|
|---|---|
|Provision at the startofthe period|2,653|
|Discount factor interest expense|23|
|Deficit contribution paid|(1,086)|
|Remeasurement -Impactofchange in assumptions|(57)|
|Provision at endofperiod31December 2022|1,533|



## 

|Net incomeforthereporting period(asper t heSOFA)<br>Adjustments for:<br>Amortisation and depreciation charges<br>Losseson investments<br>Dividendsfrominvestments<br>Bank interest<br>(lncrease)/decrease in debtors<br>Decrease in creditors<br>Netcash provided by operating activities|**2022**<br>£<br>522,675<br>46,496<br>16,152<br>(2,099)<br>(14,833)<br>(552,318)<br>(16,192)<br>**(119)**|**2021**<br>£<br>193,843<br>78,037<br>(1,688)<br>238,370<br>(432,633)<br>**75,929**|
|---|---|---|





## 

## 

|**23Analysisofcashandcashequivalents**<br>Cashinhand<br>Notice deposits (lessthan3months)<br>Total cashandcashequivalents|**2022**<br>£<br>1,202<br>2,314,421<br>**2,315,623**|**2021**<br>£<br>1,123<br>2,771,667<br>**2,772,790**|
|---|---|---|



|**Analysisofchanges in netdebt**<br>**Balanceat**<br>**1 January 2022**<br>Cash<br>1,123<br>Cash equivalents<br>2,771,667<br>2,772,790|**Cashflows**<br>79<br>(457,246)<br>(457,167)<br>**Balanceat**<br>**31 December 2022**<br>1,202<br>2,314,421<br>2,315,623|
|---|---|



